Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Merck KGaA

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Merck KGaA's 2013 sales performance.

Merck KGaA

Merck, Pfizer cue up first EU launches for PD-L1 drug Bavencio

Merck, Pfizer cue up first EU launches for PD-L1 drug Bavencio Merck KGaA and Pfizer's PD-L1 inhibitor Bavencio could be on the EU market from next month, after getting EMA approval as a treatment for the rare skin cancer Merkel ... The new product will be launched first in the UK and Germany, according to Merck,

Merck mulls sale of consumer health division

Merck mulls sale of consumer health division Merck KGaA says it is thinking about selling or partnering its consumer healthcare unit, narrowing its healthcare focus to biopharma development. ... We have maintained a solid position in attractive markets, and demonstrated a pattern of profitable

NICE expands Merck KGaA’s Erbitux reach

NICE expands Merck KGaA’s Erbitux reach Backs the medicines use for patients with SCCHN. After several attempts, Merck KgAa has finally persuaded the UK medicines cost-effectiveness watchdog to back its monoclonal antibody Erbitux (cetuximab), for use ... Byrne added: “Merck has worked

Ocrevus off to a flying start as Roche raises 2017 forecasts

Ocrevus off to a flying start as Roche raises 2017 forecasts The take-up of the drug has been buoyed by trials showing that the drug outperformed Merck KGaA's MS stalwart Rebif (interferon beta-1a) in two relapsing MS phase III

CHMP backs three immuno-oncology drugs for solid tumours

CHMP backs three immuno-oncology drugs for solid tumours Roche, MSD and Merck/Pfizer are all on course for new European approvals later this year. ... The Committee for Medicinal Products for Human Use (CHMP) recommended approval of Merck KGaA and Pfizer's Bavencio (avelumab) for Merkel cell carcinoma (MCC) -

[ Previous 5 results ] 13 14 15 16 17 18 19 20 21 22 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

The Patient Will See You Now – The Evolution of the Doctor-Patient Relationship
The doctor-patient relationship is an ever changing one that changes as society changes. Technology then helps to drive this change along with a wide number of other factors....
Mind the Gap – Challenging Immunisation Apathy and Misinformation
world, the biggest challenges remain apathy and misinformation. Since a measles vaccine was introduced in the UK in 1968, Public Health England estimates that 20 million measles cases and 4,500...
Towards Better HCP Engagement – An Email Masterclass
6% of HCPs prefer being contacted by email, compared to 17% who favour the second most popular option: direct interaction with reps....